Skip to main content
logo
OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.660
+0.040 (1.53%)
Oct 30, 2026, 12:23 PM EDT - Market open

OnKure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-58.71-59.52-52.67-35.31-29.51
Depreciation & Amortization
0.80.830.660.560.39
Other Amortization
--0.14--
Loss (Gain) From Sale of Assets
0.010.01---
Loss (Gain) From Sale of Investments
-0.03-0.05--
Stock-Based Compensation
11.8111.634.530.20.05
Other Operating Activities
--0.12--
Change in Accounts Payable
-0.74-4.55-5.931.712.65
Change in Other Net Operating Assets
-0.98-0.241.98-1.71-0.53
Operating Cash Flow
-47.84-51.83-51.12-34.55-26.95
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0.02-0.05-0.05-0.25-1.13
Investment in Securities
-9.87-15.93--
Investing Cash Flow
-9.89-0.0515.87-0.25-1.13

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
--6--
Net Debt Issued (Repaid)
--6--
Issuance of Common Stock
150.440.2458.910.070.34
Other Financing Activities
-9.58-0.0851.22-0.72-1.38
Financing Cash Flow
140.860.16116.1353.1326.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
83.13-51.7180.8918.33-1.62

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-47.86-51.87-51.17-34.79-28.09
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.11-3.84-14.84-122.59-
Levered Free Cash Flow
-27.11-31.1-23.71-22.69-
Unlevered Free Cash Flow
-27.1-31.1-23.76-22.69-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
-1.72-4.78-3.950.012.12
SEC Filings: 10-K · 10-Q